- Home
- CEPU vs ATRC Comparison
CEPU vs ATRC Comparison
Compare CEPU & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- ATRC
- Stock Information
- Founded
- CEPU 1989
- ATRC 2000
- Country
- CEPU Argentina
- ATRC United States
- Employees
- CEPU N/A
- ATRC N/A
- Industry
- CEPU Electric Utilities: Central
- ATRC Medical/Dental Instruments
- Sector
- CEPU Utilities
- ATRC Health Care
- Exchange
- CEPU Nasdaq
- ATRC Nasdaq
- Market Cap
- CEPU 1.6B
- ATRC 1.7B
- IPO Year
- CEPU 2018
- ATRC 2005
- Fundamental
- Price
- CEPU $9.92
- ATRC $37.03
- Analyst Decision
- CEPU
- ATRC Strong Buy
- Analyst Count
- CEPU 0
- ATRC 10
- Target Price
- CEPU N/A
- ATRC $49.60
- AVG Volume (30 Days)
- CEPU 523.9K
- ATRC 350.7K
- Earning Date
- CEPU 11-07-2025
- ATRC 10-29-2025
- Dividend Yield
- CEPU 3.13%
- ATRC N/A
- EPS Growth
- CEPU N/A
- ATRC N/A
- EPS
- CEPU 0.12
- ATRC N/A
- Revenue
- CEPU $628,806,380.00
- ATRC $499,946,000.00
- Revenue This Year
- CEPU $11.09
- ATRC $16.32
- Revenue Next Year
- CEPU $10.25
- ATRC $12.37
- P/E Ratio
- CEPU $9.99
- ATRC N/A
- Revenue Growth
- CEPU N/A
- ATRC 16.28
- 52 Week Low
- CEPU $7.43
- ATRC $27.32
- 52 Week High
- CEPU $16.60
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- CEPU 57.66
- ATRC 55.97
- Support Level
- CEPU $7.60
- ATRC $35.03
- Resistance Level
- CEPU $8.09
- ATRC $36.83
- Average True Range (ATR)
- CEPU 0.67
- ATRC 1.24
- MACD
- CEPU 0.29
- ATRC 0.14
- Stochastic Oscillator
- CEPU 82.66
- ATRC 85.53
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.